 Effect indecainide patients left ventricular dysfunction Indecainide new antiarrhythmic agent type Ic patients heart disease equal ventricular premature complexes/hour moderate-to-marked ventricular dysfunction mean ejection fraction Patients mg mouth hours dose equal suppression adverse effects maximum dose mg indecainide hours Ventricular premature complexes equal patients ventricular tachycardia episodes patients effective maximal mean daily indecainide dose mg half responders achieved efficacy serum drug concentration equal ng/ml Serum drug concentration clearance ejection fraction Indecainide mean PR QRS intervals QT QTc linear relation percent change PR QRS intervals serum drug concentration dose careful observation patients decreased renal function reduced ejection fraction drug concentration normal subjects